Loading provider…
Loading provider…
Neurology Physician in New York, NY
NPI: 1053623934Primary Practice Location
NEW YORK-PRESBYTERIAN HOSPITAL
5141 Broadway, New York, NY
Primary Employer
Trustees of Columbia University in the City of New York
columbiadoctors.org
HQ Phone
Get M.D. Fabio's Phone Numberphone_androidMobile
Get M.D. Fabio's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
FL State Medical License
2021
CT State Medical License
2021 - 2025
NJ State Medical License
2021 - 2025
NY State Medical License
2012 - 2025
PA State Medical License
2006 - 2012

American Board of Psychiatry and Neurology
Neurology
New York Presbyterian Hospital (Cornell Campus)
Residency • Neurology
2002 - 2006
Federal University of Parana Faculty of Medicine
Medical School
Until 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 79 | 307 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 35 | 60 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 20 | 21 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 16 | 41 |
Authors: Carlen Yuen, Rajiv Magge, Ran Reshef, Aya Haggiagi, Sarah Wesley, Jing-Mei Hsu
Journal: J Immunother
Publication Date: 2022-04-11
Authors: Jeffrey Bruce, Guy Mckhann, Jonathan Yun, Sameer Sheth, Edward Connolly, Govind Bhagat, Michael Sisti, Peter Canoll
Journal: J Neurooncol
Publication Date: 2017-01-23
Lead Sponsor: Sapience Therapeutics
Intervention / Treatment: DRUG: Temozolomide, RADIATION: Radiation, DRUG: ST101
Lead Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, DRUG: Temozolomide, DRUG: Lomustine, RADIATION: Photon Beam Radiation Therapy
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Biospecimen Collection, PROCEDURE: Conventional Surgery, RADIATION: Fractionated Stereotactic Radiation Therapy, BIOLOGICAL: Atezolizumab, BIOLOGICAL: Tocilizumab